Biology of allografting.

Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med (2005) 2.10

Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res (2005) 2.04

A perspective: engineering periosteum for structural bone graft healing. Clin Orthop Relat Res (2008) 1.57

Studies of bone morphogenetic protein-based surgical repair. Adv Drug Deliv Rev (2012) 1.13

Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration. J Mater Sci Mater Med (2003) 0.96

Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair. Adv Drug Deliv Rev (2015) 0.91

Quantification of massive allograft healing with dynamic contrast enhanced-MRI and cone beam-CT: a pilot study. Clin Orthop Relat Res (2008) 0.86

Femoral osteolysis following total hip replacement. Postgrad Med J (2007) 0.85

The Axolotl Fibula as a Model for the Induction of Regeneration across Large Segment Defects in Long Bones of the Extremities. PLoS One (2015) 0.76

Knockdown of toll-like receptor 4 signaling pathways ameliorate bone graft rejection in a mouse model of allograft transplantation. Sci Rep (2017) 0.75

Effect of serum-derived albumin scaffold and canine adipose tissue-derived mesenchymal stem cells on osteogenesis in canine segmental bone defect model. J Vet Sci (2015) 0.75

Effects of a new allograft processing procedure on graft healing in a canine model: a preliminary study. Clin Orthop Relat Res (2008) 0.75

A Population-Based 16-Year Study on the Risk Factors of Surgical Site Infection in Patients after Bone Grafting: A Cross-Sectional Study in Taiwan. Medicine (Baltimore) (2015) 0.75

Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am (1999) 4.58

Fractures of the femur after hip replacement. Instr Course Lect (1995) 3.08

Removal of well-fixed, cementless, acetabular components in revision hip arthroplasty. J Bone Joint Surg Br (2003) 2.33

The PROSTALAC functional spacer in two-stage revision for infected knee replacements. Prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg Br (2000) 1.70

The reliability and validity of the Vancouver classification of femoral fractures after hip replacement. J Arthroplasty (2000) 1.61

The prevention of periprosthetic fractures in total hip and knee arthroplasty. Orthop Clin North Am (1999) 1.55

The management of peri-prosthetic infection in total joint arthroplasty. J Bone Joint Surg Br (2006) 1.53

Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study. J Bone Joint Surg Br (2009) 1.52

Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty (1996) 1.48

Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg (2001) 1.48

The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty (1997) 1.42

MR imaging features of bizarre parosteal osteochondromatous proliferation of bone (Nora's lesion). Eur J Radiol (2001) 1.38

Arterial complications and total knee arthroplasty. J Am Acad Orthop Surg (2001) 1.38

The function of antigen-presenting cells in mice with severe combined immunodeficiency. J Immunol (1985) 1.36

Heterogeneity of stimulator cells in the murine mixed leukocyte response. Eur J Immunol (1982) 1.32

Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst (1991) 1.28

Treatment of infection associated with segmental bone loss in the proximal part of the femur in two stages with use of an antibiotic-loaded interval prosthesis. J Bone Joint Surg Am (1998) 1.20

Sternal metastases and associated pathological fractures. Thorax (1977) 1.18

Stimulator cell requirements for allospecific T cell subsets: specialized accessory cells are required to activate helper but not cytolytic T lymphocyte precursors. J Immunol (1983) 1.16

The role of antibiotic-loaded cement in the treatment of an infection after a hip replacement. Instr Course Lect (1995) 1.12

The expectations of patients undergoing revision hip arthroplasty. J Arthroplasty (2001) 1.11

Periprosthetic fractures of the femur: principles of prevention and management. Instr Course Lect (1998) 1.10

Classification of the hip. Orthop Clin North Am (1999) 1.08

The treatment of the infected hip replacement. The complex case. Clin Orthop Relat Res (1999) 1.08

Femoral bone loss in total hip arthroplasty: classification and preoperative planning. Instr Course Lect (2000) 1.06

Structural proximal femoral allografts for failed total hip replacements: a minimum review of five years. J Bone Joint Surg Br (2000) 1.05

Ossifying lipoma of the thigh. Br J Radiol (2008) 1.03

Rheumatology: 10. Joint replacement of the hip and knee--when to refer and what to expect. CMAJ (2000) 1.01

Reliability of acetabular bone defect classification systems in revision total hip arthroplasty. J Arthroplasty (2001) 1.00

Diagnosis of infection following total hip arthroplasty. Instr Course Lect (1998) 1.00

Treatment of infection at the site of total hip replacement. Instr Course Lect (1998) 1.00

Alloreactive cytotoxic T lymphocyte responses to H-2 products on purified accessory cells. Immunology (1982) 1.00

The role of intraoperative gram stain in the diagnosis of infection during revision total hip arthroplasty. J Arthroplasty (1999) 0.99

Giant cell tumor of bone with selective metastases to mediastinal lymph nodes. Skeletal Radiol (1998) 0.98

Role of polyethylene oxidation and consolidation defects in cup performance. Clin Orthop Relat Res (1998) 0.98

The treatment of periprosthetic fractures of the femur using cortical onlay allograft struts. Orthop Clin North Am (1999) 0.97

Circumferential allograft replacement of the proximal femur. A critical analysis. Clin Orthop Relat Res (2000) 0.97

Surgical exposures in revision total knee arthroplasty. J Am Acad Orthop Surg (1998) 0.97

The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R bone cements. J Arthroplasty (1999) 0.96

Functional evaluation in distal femoral endoprosthetic replacement for bone sarcoma. Clin Orthop Relat Res (2001) 0.95

Popliteal vascular malformation simulating a soft tissue sarcoma. Skeletal Radiol (1999) 0.95

Predictors of quality of life outcomes after revision total hip replacement. J Bone Joint Surg Br (2007) 0.95

Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells. Eur J Immunol (1990) 0.94

The cement mantle in the Exeter impaction allografting technique. A cause for concern. J Arthroplasty (1997) 0.93

Temporary antibiotic loaded acrylic hip replacement: a novel method for management of the infected THA. Semin Arthroplasty (1994) 0.93

Intravascular embolisation and surgical resection of a giant neurofibroma with intratumoural haemorrhage. Br J Radiol (2010) 0.92

Epithelioid angiosarcoma arising in a surgically constructed arteriovenous fistula: a rare complication of chronic immunosuppression in the setting of renal transplantation. Am J Surg Pathol (1998) 0.92

Comparative repeatability of guide-pin axis positioning in computer-assisted and manual femoral head resurfacing arthroplasty. Proc Inst Mech Eng H (2007) 0.91

Pictorial review: giant cell tumours of bone. Clin Radiol (1998) 0.91

Lipomatous hemangiopericytoma: a morphologically distinct soft tissue tumor. Arch Pathol Lab Med (1999) 0.90

Conversion of hip arthrodesis to total hip arthroplasty. Instr Course Lect (2001) 0.89

Primary total replacement of the dysplastic hip. Instr Course Lect (2000) 0.89

Stimulator requirements for primed alloreactive T cells: macrophages and dendritic cells activate T cells across all genetic disparities. Cell Immunol (1985) 0.88

Ontogeny of priming of cytotoxic T cells to minor alloantigens: the development of direct priming precedes that of cross-priming. Eur J Immunol (1986) 0.88

Treatment of hip instability. Orthop Clin North Am (2001) 0.88

Porous tantalum uncemented acetabular shells in revision total hip replacement: two to four year clinical and radiographic results. Hip Int (2008) 0.88

Clinical and radiographic assessment of the young adult with symptomatic hip dysplasia. Clin Orthop Relat Res (2004) 0.87

Impaction allografting with cement for the management of femoral bone loss. Orthop Clin North Am (1998) 0.87

Femoral bone loss in patients managed with revision hip replacement: results of circumferential allograft replacement. Instr Course Lect (2000) 0.87

Collapsed vertebrae: a review of 659 autopsies. Clin Orthop Relat Res (1978) 0.86

Bone and cartilage allotransplantation. A review of 14 years of research and clinical studies. Clin Orthop Relat Res (1986) 0.86

Unanticipated variations between expected and delivered pneumatic compression therapy after elective hip surgery: a possible source of variation in reported patient outcomes. J Arthroplasty (2001) 0.86

Articulating antibiotic impregnated spacers in two-stage revision of infected total knee arthroplasty. J Bone Joint Surg Br (2012) 0.86

Tapered fluted modular titanium stems in the management of Vancouver B2 and B3 peri-prosthetic fractures. Bone Joint J (2013) 0.86

Computed tomography topographic mapping of subchondral density (CT-TOMASD) in osteoarthritic and normal knees: methodological development and preliminary findings. Osteoarthritis Cartilage (2009) 0.85

Suppression of the proliferative response to H-2D by I-J subregion gene products. Immunogenetics (1980) 0.85

Characterization of stimulator cells for alloreactive cytotoxic-T-lymphocyte responses in vivo. Cell Immunol (1985) 0.85

Fixation of trochanteric slide osteotomies: a biomechanical study. Clin Biomech (Bristol, Avon) (2003) 0.83

Ulnar variance in carpal instability. J Hand Surg Am (1987) 0.82

Determinants of patellar tracking in total knee arthroplasty. Clin Biomech (Bristol, Avon) (2008) 0.82

Fractures Involving the Distal Epiphyseal plate of the femur. Int Orthop (1981) 0.82

Use of reconstruction rings for the management of acetabular bone loss during revision hip surgery. J Am Acad Orthop Surg (1999) 0.82

Allospecific T-cell lines with functional activities. Immunology (1982) 0.82

The extensile rectus snip exposure in revision of total knee arthroplasty. J Bone Joint Surg Br (2003) 0.82

The cement mantle in femoral impaction allografting. A comparison of three systems from four centres. J Bone Joint Surg Br (1997) 0.81

Primary total hip arthroplasty after infection. Instr Course Lect (2001) 0.81

Role and results of segmental allografts for acetabular segmental bone deficiency. Orthop Clin North Am (1998) 0.81

Surgical approaches in revision hip replacement. J Am Acad Orthop Surg (1998) 0.80

The presentation of cell surface alloantigens to T cells. Immunobiology (1984) 0.80

Periprosthetic fractures: an operative algorithm. Orthopedics (2001) 0.79

Finding and defining the ideal patellar resection plane in total knee arthroplasty. J Biomech (2009) 0.79

Acetabular bone loss during revision total hip replacement: preoperative investigation and planning. Instr Course Lect (1999) 0.78

Distribution of actin in spermatids and adjacent Sertoli cell regions of the rat. Anat Rec (1987) 0.78

Preoperative planning to prevent instability in total knee arthroplasty. Orthop Clin North Am (2001) 0.78

Intraoperative vs. weightbearing patellar kinematics in total knee arthroplasty: a cadaveric study. Clin Biomech (Bristol, Avon) (2007) 0.78

A comparative study of accessory cells derived from the peritoneum and from solid tissues. Adv Exp Med Biol (1982) 0.78

Antigen presenting cells and bone allotransplantation. Clin Orthop Relat Res (1985) 0.77

Role and results of tapered fluted modular titanium stems in revision total hip arthroplasty. J Bone Joint Surg Br (2012) 0.77

Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors. J Immunol (1984) 0.77

Bone banks and allografts in community practice. Instr Course Lect (1988) 0.77

I. Characterization of cytotoxic effector cells generated from regional lymph nodes after immunization in the footpad. Immunology (1983) 0.77

[Fresh osteochondral transplants in the treatment of advanced giant cell tumors]. Orthopade (1993) 0.77

Allograft impaction and cement penetration after revision hip replacement. A histomorphometric analysis in the cadaver femur. J Bone Joint Surg Br (2004) 0.77

The biology of bone grafting. Instr Course Lect (1999) 0.76

Sciatic nerve resection in the thigh: a functional evaluation. Clin Orthop Relat Res (2001) 0.76

The biology, pathology and immunology of a virus induced rat osteosarcoma. I. Biological behaviour and histopathology. Int Orthop (1980) 0.75

Local excision without radiation for high-grade soft-tissue sarcoma of the extremity and superficial trunk. Sarcoma (2000) 0.75

Virus-induced osteosarcoma in rats. J Bone Joint Surg Am (1976) 0.75

Primary T-cell responses to minor alloantigens. II. Analysis of accessory cell requirements for the development of cytotoxic T lymphocytes. Immunology (1983) 0.75

Freeze-dried cortical allografts. Orthopedics (1998) 0.75